Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) insider Thomas E. Mazurek sold 4,285 shares of the stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total transaction of $209,493.65. Following the sale, the insider now owns 45,992 shares of the company's stock, valued at approximately $2,248,548.88. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Bath & Body Works Trading Up 1.2 %
NYSE:BBWI opened at $50.02 on Friday. The firm has a 50-day moving average price of $45.20 and a two-hundred day moving average price of $38.82. Bath & Body Works, Inc. has a twelve month low of $27.30 and a twelve month high of $50.17. The company has a market capitalization of $11.25 billion, a P/E ratio of 12.99, a price-to-earnings-growth ratio of 1.65 and a beta of 1.85.
Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The firm had revenue of $2.91 billion during the quarter, compared to the consensus estimate of $2.84 billion. During the same period last year, the firm posted $1.86 EPS. The firm's revenue for the quarter was up .8% on a year-over-year basis. On average, equities research analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.
Bath & Body Works Dividend Announcement
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
From Colonial Metals | Ad
The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold.
The firm also recently announced a quarterly dividend, which was paid on Friday, March 8th. Shareholders of record on Friday, February 23rd were issued a dividend of $0.20 per share. The ex-dividend date was Thursday, February 22nd. This represents a $0.80 annualized dividend and a yield of 1.60%. Bath & Body Works's dividend payout ratio (DPR) is currently 20.78%.
Institutional Investors Weigh In On Bath & Body Works
A number of hedge funds and other institutional investors have recently modified their holdings of BBWI. Denali Advisors LLC acquired a new stake in shares of Bath & Body Works in the fourth quarter worth approximately $27,000. GAMMA Investing LLC purchased a new stake in shares of Bath & Body Works during the fourth quarter valued at approximately $27,000. Money Concepts Capital Corp increased its stake in shares of Bath & Body Works by 1,180.4% in the fourth quarter. Money Concepts Capital Corp now owns 653 shares of the company's stock worth $28,000 after buying an additional 602 shares during the last quarter. Front Row Advisors LLC bought a new stake in shares of Bath & Body Works in the third quarter worth $25,000. Finally, Trust Co. of Vermont bought a new stake in Bath & Body Works during the third quarter valued at $27,000. 95.14% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of analysts recently weighed in on BBWI shares. Barclays cut shares of Bath & Body Works from an "overweight" rating to an "equal weight" rating and increased their price target for the stock from $37.00 to $45.00 in a research note on Thursday, January 4th. Telsey Advisory Group restated an "outperform" rating and issued a $53.00 target price (up previously from $50.00) on shares of Bath & Body Works in a research note on Thursday, February 29th. The Goldman Sachs Group raised their target price on shares of Bath & Body Works from $49.00 to $56.00 and gave the stock a "buy" rating in a research note on Monday, March 4th. Wells Fargo & Company raised their target price on shares of Bath & Body Works from $40.00 to $42.00 and gave the stock an "equal weight" rating in a research note on Friday, March 1st. Finally, UBS Group raised their target price on shares of Bath & Body Works from $46.00 to $52.00 and gave the stock a "neutral" rating in a research note on Monday, March 4th. One analyst has rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, Bath & Body Works presently has an average rating of "Hold" and an average target price of $45.80.
Check Out Our Latest Stock Analysis on Bath & Body Works
Bath & Body Works Company Profile
(
Get Free Report)
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
